中文簡介

《生物制藥統(tǒng)計(jì)》是一本快速發(fā)表的雜志，討論了統(tǒng)計(jì)學(xué)在生物制藥研究和開發(fā)中的質(zhì)量應(yīng)用。現(xiàn)在每年出版六次，它包括了統(tǒng)計(jì)方法論的論述，并以全長和短稿、評(píng)論文章、選定/邀請(qǐng)的會(huì)議論文、短篇文章和編輯信的形式直接適用于這類作品。該期刊涵蓋了對(duì)生物統(tǒng)計(jì)專業(yè)至關(guān)重要的及時(shí)和挑釁性主題：藥物、裝置和生物研究與開發(fā)藥物篩選與藥物設(shè)計(jì)藥理活性評(píng)價(jià)藥物配方和擴(kuò)大規(guī)模臨床前安全評(píng)估生物利用度、生物等效性和藥動(dòng)學(xué)I、II和III期臨床開發(fā)上市前臨床安全性評(píng)價(jià)郵戳監(jiān)控

投稿網(wǎng)址：https://mc.manuscriptcentral.com/lbps

英文簡介

The Journal of Biopharmaceutical Statistics, a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to such work in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers:Drug, device, and biological research and development Drug screening and drug design Assessment of pharmacological activity Pharmaceutical formulation and scale-up Preclinical safety assessment Bioavailability, bioequivalence, and pharmacokinetics Phase, I, II, and III clinical development Premarket approval assessment of clinical safety Postmarketing surveillance